EUVIMEDEUVIMED entdecken
Open Access

Mac-1 regulates disease stage–specific immunosuppression via the nitric oxide pathway in autoimmune disease

Wei Wang iD, Chunzhang Cao iD, Vishnuprabu Durairaj Pandian iD, Haofeng Ye, Hongxia Chen iD, Li Zhang iD

Science Advances · 2025

DOI: 10.1126/sciadv.ads3728 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Wei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Center for Vascular and Inflammatory Diseases, School of Medicine, University of Maryland, Baltimore, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Nitric Oxide, Macrophage-1 Antigen, Signal Transduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Integrin Mac-1 plays a critical role in the development of multiple sclerosis (MS); however, the underlying mechanism is not fully understood. Here, we developed a myeloid-specific Mac-1–deficient mouse. Using an experimental autoimmune encephalomyelitis (EAE) mouse model of MS, we report that Mac-1 on myeloid cells is key to disease development. Our data reveal that myeloid-specific Mac-1 significantly increases EAE severity and hinders disease regression. Loss of Mac-1 increases Gr-1 + cells in peripheral tissues and the CNS and preferably accelerates the transition of Ly6C hi monocytes from a pro-inflammatory to an immunosuppressive phenotype in a disease stage–dependent manner. Mechanistically, our results demonstrate that Mac-1 suppresses interferon-γ production and prevents monocytes from acquiring immunosuppressive functions by reducing the expression of iNOS, IDO, and CD84. Administration of a NOS-specific inhibitor in Mac-1–deficient EAE mice abolishes disease regression. These insights could help develop Mac-1–targeting strategies for better treatment of MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalNitric OxideMacrophage-1 AntigenSignal TransductionImmune ToleranceAutoimmune DiseasesAnimalsMiceDisease Models, AnimalMice, KnockoutMultiple SclerosisMonocytesMice, Inbred C57BLFemale

Substanzen

Nitric OxideMacrophage-1 Antigen

Autor:innen und Institutionen

  • Department of Physiology, Center for Vascular and Inflammatory Diseases, School of Medicine, University of Maryland, Baltimore, Baltimore, MD, USA.
  • Johns Hopkins Advanced Academic Programs, Johns Hopkins University of Arts and Sciences, Baltimore, MD, USA.

ORCID-Profile: Wei Wang, Chunzhang Cao, Vishnuprabu Durairaj Pandian, Hongxia Chen, Li Zhang

Förderung

  • NHLBI NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Wang, W., Cao, C., Pandian, V. D., Ye, H., Chen, H., & Zhang, L. (2025). Mac-1 regulates disease stage–specific immunosuppression via the nitric oxide pathway in autoimmune disease. Science Advances. https://doi.org/10.1126/sciadv.ads3728

Vancouver

Wang W, Cao C, Pandian VD, Ye H, Chen H, Zhang L. Mac-1 regulates disease stage–specific immunosuppression via the nitric oxide pathway in autoimmune disease. Science Advances. 2025. doi:10.1126/sciadv.ads3728

BibTeX
@article{Wang2025,
  author = {Wang, Wei and Cao, Chunzhang and Pandian, Vishnuprabu Durairaj and Ye, Haofeng and Chen, Hongxia and Zhang, Li},
  title = {Mac-1 regulates disease stage–specific immunosuppression via the nitric oxide pathway in autoimmune disease},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.ads3728}
}
Kostenlos starten →